Mesenchymal stem cells (MSCs) have attracted lots of attention for the treatment of acute liver failure and end-stage liver diseases. This study aimed at investigating the fundamental mechanism by which bone marrow-derived MSCs (BM-MSCs) induce liver regeneration of fibrotic liver in rats. Rats underwent bile duct ligation (BDL) surgery and four weeks later they were treated with either BM-MSCs (3 × 106 cells /rat, once, tail vein injection) or silymarin (100 mg/kg, daily, orally) for four weeks. Liver function tests and hepatic oxidative stress were determined. Hepatic injury and fibrosis were assessed by H and E, Sirus red staining and immunohistochemical expression of α-smooth muscle actin (α-SMA). Hepatocyte growth factor (HGF) and the gene expression of cytokeratin-19 (CK-19) and matrix metalloproteinase-2 (MMP-2) in liver tissue were determined. BDL induced cholestatic liver injury characterized by elevated ALT and AST activities, bilirubin and decreased albumin. The architecture damage was staged as Metavir score: F3, A3. Fibrosis increased around proliferating bile duct as indicated by sirus red staining and α-SMA immunostaining. Fibrogenesis was favored over fibrolysis and confirmed by decreased HGF with increased expression of CK-19, but decreased MMP-2 expression. BM-MSCs treatment restored deteriorated liver functions and restored the histological changes, resolved fibrosis by improving liver regenerative capabilities (P < 0.001), increases in HGF and MMP-2 mRNA and downregulating CK-19 mRNA. Sliymarin, however, induced similar but less prominent effects compared to BM-MSCs. In conclusion, liver regenerative capabilities can be stimulated by BM-MSCs via augmentation of HGF that subsequently up-regulate MMP-2 mRNA while downregulating CK-19 mRNA.
LaiHSWuYMLaiSLLinWH. Lipocalin-2 gene expression during liver regeneration after partial hepatectomy in rats. Int J Surg2013; 11: 314–8.
2.
SwensonESKuwaharaRKrauseDSTheiseND. Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration. Liver Int2008; 28: 308–18.
NakamuraTSakaiKMatsumotoK. Hepatocyte growth factor twenty years on: much more than a growth factor. J Gastroenterol Hepatol2011; 26: 188–202.
5.
MungunsukhODayRM. Transforming growth factor-beta1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism. Mol Biol Cell2013; 24: 2088–97.
6.
GuiYYeganehMRamanathanSLeblancCPomerleauVFerbeyreGSaucierCIlangumaranS. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes. J Hepatol2011; 55: 1300–8.
7.
MishraAPaulSSwarnakarS. Downregulation of matrix metalloproteinase-9 by melatonin during prevention of alcohol-induced liver injury in mice. Biochimie2011; 93: 854–66.
8.
IredaleJPThompsonAHendersonNC. Extracellular matrix degradation in liver fibrosis: biochemistry and regulation. Biochim Biophys Acta2013; 1832: 876–83.
9.
ChoiSSDiehlAM. Epithelial-to-mesenchymal transitions in the liver. Hepatology2009; 50: 2007–13.
10.
KoikeHTaniguchiH. Characteristics of hepatic stem/progenitor cells in the fetal and adult liver. J Hepatobiliary Pancreat Sci2012; 19: 587–93.
11.
SunCKChenCHKaoYHYuenCMSheuJJLeeFYChenYTKungCTYipHK. Bone marrow cells reduce fibrogenesis and enhance regeneration in fibrotic rat liver. J Surg Res2011; 169: e15–26.
12.
GilchristESPlevrisJN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl2010; 16: 118–29.
13.
NasirGAMohsinSKhanMShamsSAliGKhanSNRiazuddinS. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. J Transl Med2013; 11: 78–78.
14.
ChangYJLiuJWLinPCSunLYPengCWLuoGHChenTMLeeRPLinSZHarnHJChiouTW. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci2009; 85: 517–25.
15.
ZhengLChuJShiYZhouXTanLLiQCuiLHanZHanYFanD. Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17. Cell Biosci2013; 3: 46–46.
16.
van PollDParekkadanBChoCHBerthiaumeFNahmiasYTillesAWYarmushML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology2008; 47: 1634–43.
17.
ChoKAJuSYChoSJJungYJWooSYSeohJYHanHSRyuKH. Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biol Int2009; 33: 772–7.
18.
FeherJLengyelG. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Curr Pharm Biotechnol2012; 13: 210–17.
19.
ShakerEMahmoudHMnaaS. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food Chem Toxicol2010; 48: 803–6.
Abdel AzizMTWassefMARashedLAMhfouzSOmarNElsebaieMM. Mesenchymal stem cells therapy in acute renal failure: possible role of hepatocyte growth factor. J Stem Cell Res Ther2011; 1: 109–15.
22.
LiuYBinzJNumerickMJDennisSLuoGDesaiBMacKenzieKIMansfieldTAKliewerSAGoodwinBJonesSA. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest2003; 112: 1678–87.
JohnstoneJMLeeEG. A quantitative assessment of the structural changes the rat's liver following obstruction of the common bile duct. Br J Exp Pathol1976; 57: 85–94.
MohamedHEElswefySERashedLAYounisNNShaheenMAGhanimAMH. Cholestatic liver fibrosis in a rat model of bile duct ligation: evaluating biochemical versus histopathological changes. IJPPS2015; 7: 349–54.
28.
SnowdonVKFallowfieldJA. Models and mechanisms of fibrosis resolution. Alcohol Clin Exp Res2011; 35: 794–9.
29.
El-SwefySHassanenSI. Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats. Ann Hepatol2009; 8: 41–9.
30.
MuchovaLVanovaKZelenkaJLenicekMPetrTVejrazkaMSticovaEVremanHJWongRJVitekL. Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress. J Cell Mol Med2011; 15: 1156–65.
31.
WangGShenHRajaramanGRobertsMSGongYJiangPBurczynskiF. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Eur J Pharmacol2007; 560: 61–8.
32.
LeeWJParkSERahDK. Effects of hepatocyte growth factor on collagen synthesis and matrix metalloproteinase production in keloids. J Korean Med Sci2011; 26: 1081–6.
33.
JiaoKSunQChenBLiSLuJ. Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats. Scand J Gastroenterol2014; 49: 715–21.
34.
YuJCaoHYangJPanQMaJLiJLiYWangYLiL. In vivo hepatic differentiation of mesenchymal stem cells from human umbilical cord blood after transplantation into mice with liver injury. Biochem Biophys Res Commun2012; 422: 539–45.
35.
KuoTKHungSPChuangCHChenCTShihYRFangSCYangVWLeeOK. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology2008; 134: 2111–21, e2111–3.
36.
LiYYanMYangJRamanIDuYMinSFangXMohanCLiQZ. Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation. Stem Cell Res Ther2014; 5: 19–19.
37.
SigalaFKostopanagiotouGAndreadouIKavatzasNFelekourasESigalasPBastounisEPapalambrosE. Histological and lipid peroxidation changes after administration of 2-acetylaminofluorene in a rat liver injury model following selective periportal and pericentral damage. Toxicology2004; 196: 155–63.
38.
TuncyurekPYeniseyCDogerFKSoyderABicakciTCevikelMH. Nitric oxide as an independent regulatory factor in regenerating rat liver. Acta Chir Belg2006; 106: 581–7.
39.
Aguilar-DelfinILopez-BarreraFHernandez-MunozR. Selective enhancement of lipid peroxidation in plasma membrane in two experimental models of liver regeneration: partial hepatectomy and acute CC14 administration. Hepatology1996; 24: 657–62.
40.
Matsuda-HashiiYTakaiKOhtaHFujisakiHTokimasaSOsugiYOzonoKMatsumotoKNakamuraTHaraJ. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. Exp Hematol2004; 32: 955–61.
41.
UekiTKanedaYTsutsuiHNakanishiKSawaYMorishitaRMatsumotoKNakamuraTTakahashiHOkamotoEFujimotoJ. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med1999; 5: 226–30.
42.
IshikawaTFactorVMMarquardtJURaggiCSeoDKitadeMConnerEAThorgeirssonSS. Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. Hepatology2012; 55: 1215–26.
43.
ShamsSMohsinSNasirGAKhanMKhanSN. Mesenchymal stem cells pretreated with HGF and FGF4 can reduce liver fibrosis in mice. Stem Cells Int2015; 2015: 747245–747245.
44.
AlwaynIPJVerbeseyJEKimSRoyRArsenaultDAGreeneAKNovakKLaformeALeeSMosesMAPuderM. A critical role for matrix metalloproteinases in liver regeneration. J Surg Res2008; 145: 192–8.
45.
BirdTGLuWYBoulterLGordon-KeylockSRidgwayRAWilliamsMJTaubeJThomasJAWojtachaDGambardellaASansomOJIredaleJPForbesSJ. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc Natl Acad Sci U S A2013; 110: 6542–7.
46.
ChivuMDimaSOStancuCIDobreaCUscatescuVNeculaLGBleotuCTanaseCAlbulescuRArdeleanuCPopescuI. In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors. Transl Res2009; 154: 122–32.
47.
JiaJDBauerMChoJJRuehlMMilaniSBoigkGRieckenEOSchuppanD. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1. J Hepatol2001; 35: 392–8.
48.
PradhanSCGirishC. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res2006; 124: 491–504.
49.
SonnenbichlerJZetlI. Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers. Prog Clin Biol Res1986; 213: 319–31.
